The challenge CDMO faced in 2025 and how to stay ahead

This track explores how contract development and manufacturing organizations (CDMOs) can respond to the pressures that shaped 2025 and prepare for the next phase of manufacturing competition. As pharma and biotech companies look for partners that can deliver speed, quality, flexibility, regulatory confidence, and scalable capacity, CDMOs are being pushed to move beyond traditional manufacturing support and become strategic growth partners.

The session examines the challenges CDMOs faced in 2025 — capacity constraints, pricing pressure, regulatory expectations, supply chain disruption, complex product requirements, and rising client expectations — and the capabilities needed to stay ahead: digitalization, automation, smart manufacturing, scalable equipment, quality systems, technology transfer excellence, partnership models, and regional manufacturing strengths.

Bringing together market, CDMO, technology, and local perspectives, the track helps stakeholders understand what will differentiate winning CDMOs in the years ahead, and how Thai and Southeast Asian CDMOs can align local capabilities with global standards and evolving pharma and biotech needs.